No statistically significant difference was found among the immunodeficiency host (glucocorticoid or immunosuppressant treatment), cellular immune function (CD4+ or CD8+ T lymphocytes), and infection-related inflammation markers (white blood cells or C-reactive protein) between the two groups (p > 0.05). The gene discussed is CD8A; the disease is immunodeficiency disease.